Kadimastem Ltd
KDST
주식 순위
#40943
Kadimastem Ltd is a biopharmaceutical company focused on pioneering... Kadimastem Ltd is a biopharmaceutical company focused on pioneering regenerative medical treatments. These therapies are developed using cells sourced from human embryonic stem cells, primarily targeting neurodegenerative diseases. Its development pipeline features AstroRx, a clinical-grade human astrocyte product currently undergoing Phase 1/2a clinical trials for amyotrophic lateral sclerosis (ALS) and various other neurodegenerative conditions. Additionally, the company is advancing IsletRx, a clinical-grade pancreatic islet cell therapy intended for the treatment of diabetes. Incorporated in 2008, Kadimastem is headquartered in Ness Ziona, Israel.
주가
$12.16
마지막 동기화: 2025-10-30
시가총액
$50.98K
변동 (1일)
-0.10%
변동 (1년)
69.56%
국가
IL
거래 Kadimastem Ltd (KDST)
카테고리
Healthcare
Kadimastem Ltd (KDST)의 주가 이력
최고 종가: $3.43 (2025-12-01 기준)
최저 종가: $8.68 (2021-01-01 기준)
최저 종가: $8.68 (2021-01-01 기준)
Kadimastem Ltd의 주가 이력 (2021 ~ 2026)
연간 주가 성과
| 연도 | 성과 |
|---|---|
| 2026 (TTM) | 27.09% |
| 2025 | -62.21% |
| 2024 | -1.52% |
| 2023 | 0.00% |
| 2022 | -67.49% |
| 2021 | 0.00% |
유사 기업 또는 경쟁사의 주가
| 회사 | 주가 | 변동률 1년% | 국가 |
|---|---|---|---|
| $527.18 | 23.62% |
US
|
|
| $251.29 | 835.90% |
US
|
|
| $137.29 | -4.16% |
AU
|
|
| $890.85 | 9.42% |
NL
|
|
| $752.87 | 7.01% |
CH
|
